The News Review:

- Beyond the text book
- Biotel Announces Strong Results for the First Quarter Ended September…
- A clinician’s perspective

Beyond the text book
Express Pharma – Sep 30, 2007
What kind of a student profile are we looking at? Woodman: Since the course in Indian and UK are identical the delivery and the programme of the syllabus is also the same. So that means the entry requirements for the course is also identical. The target audience is not set by us but by the clinical research industry. We are looking at people who can directly interact with patients and administer drugs etc and then a set that is trained in pharmacology and understand how the drugs work. Most importantly the sector according to my understanding that has the quality but has not always had the greatest career opportunity; namely life science graduates. Clinical researchers need those skills as much as it needs medical and pharmacology skills and we think this is something we see here i… Lunec: This is another experience we have had in the UK. There our teaching hospitals are rather over specialised and so if you concentrate too much on a very focussed area you are not really helping out the general public. For instance we carry out clinical research in the suburban area because the diversity of problems there is greater than what are seen in the teaching hospitals. So it is very important to capture clinical opportunity. How will retraining doctors and hospital staff to be more research oriented take place? Woodman: It is interesting you use the word retraining. We like to call it ‘synergy addition’ to their training. We come from the point of view that being a research practitioner will always influence and educate any other activity you know.

Biotel Announces Strong Results for the First Quarter Ended September…
SmartBrief – Sep 30, 2007
6% year over year "We had a strong first quarter beginning our fiscal year with year over year growth in product and service revenues and improved margins" Biotel President and CE Steve Springrose said. "Compared to the first quarter of fiscal 2007 we had increased sales of our Braemar cardiac event recorders Holter devices liposuction and other medical devices. Biotel continues to serve as a development partner to medical corporations seeking new devices and clinical research services in keeping with our long-term strategy. " In the first quarter Biotel held operating expenses flat from a year ago even with a 10. 3% increase in Research and Development. "We continued to put emphasis on R&D to expand our proprietary technology across our product spectrum" Springrose commented.

A clinician’s perspective
Express Pharma – Sep 30, 2007
The closing session of day one was a presentation by Dr C T Rao Vice-President R&D (Medicinal Chemistry) Sun Pharma Advanced Research Company spoke on inflammation therapeutic strategies for TNF Inhibition. The opening session of the day two of the conference was a paper by Dr Prakash V Diwan Head Pharmacology IICT on inflammation: Pharmacotherapeutic approa-ches who spoke comprehensively on new developments in treatment of inflammation and challenges ahead. This was followed by a presentation on pre-clinical development of anti-inflammatory drugs by Dr Kalyanasundram CS Strand Life Sciences. "The conventional serial approach to designing molecules has a low hit rate and is time consuming. An integrated approach (in-silico in-vitro and in-vivo) has a potential to improve this performance tremendously" said Dr Kalyanasundram.